This inventor holds 1 USPTO granted patent. Top assignees: Bioiberica, S.a., Progenika Biopharma S.a.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Ainara Cadaval: Innovator in Osteoporosis Diagnostics
Introduction
Ainara Cadaval is a prominent inventor based in Derio, Spain. She has made significant contributions to the field of osteoporosis diagnostics through her innovative methods and research. Her work focuses on understanding genetic variations associated with osteoporosis, which is crucial for developing effective treatments and preventive measures.
Latest Patents
Ainara holds a patent for a diagnostic method that prognoses osteoporosis phenotypes and estimates quantitative traits. This method involves determining outcomes for selected SNP variables and clinical variables. Additionally, her patent includes products and methods for genotyping multiple osteoporosis-associated genetic variations. This innovative approach has the potential to enhance the accuracy of osteoporosis diagnosis and treatment.
Career Highlights
Throughout her career, Ainara has worked with notable companies such as Progenika Biopharma S.A. and Bioiberica S.A. Her experience in these organizations has allowed her to apply her expertise in genetics and diagnostics, contributing to advancements in the field of osteoporosis research.
Collaborations
Ainara has collaborated with esteemed colleagues, including Diego Tejedor Hernández and Antonio Martínez Martínez. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of osteoporosis research.
Conclusion
Ainara Cadaval's contributions to osteoporosis diagnostics through her patent and collaborative efforts highlight her role as a leading innovator in the field. Her work not only advances scientific understanding but also has the potential to improve patient outcomes in osteoporosis management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile